EMA announces final steps for its clinical-trial data policy
Access to clinical trials data impacts not only the way European scientists implement their researches, but also patients.
The European Medicines Agency (EMA) is in process of modifying its policy on the way clinical trials data are published.
For this reason, the EMA will launch a targeted discussion with key stakeholders in May to give them the opportunity to address any outstanding issues before the final policy is presented.
The final EMA policy on clinical trials data will be ready in June 2014.
You can find the complete press release on the EMA website clicking here.